Autres langues Pharmaids Pharmaceuticals Limited

Actions

PHARMAID

INE117D01018

Produits pharmaceutiques

Marché Fermé - Bombay S.E. Autres places de cotation 12:02:24 07/08/2026			Varia. 5j.	Varia. 1 janv.
34,50 ^INR	-2,82%		+11,29%	-27,61%

29/05	Pharmaids Pharmaceuticals Limited publie ses résultats pour le quatrième trimestre et l'exercice clos le 31 mars 2026	CI
12/02	Pharmaids Pharmaceuticals Limited publie ses résultats financiers pour le troisième trimestre et les neuf premiers mois clos le 31 décembre 2025	CI

Autres langues

29/05	Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026
12/02	Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025
05/01	Pharmaids Pharmaceuticals Limited Announces Completion of Term of Mopperthy Sudheer as Independent Director and Member of the Audit Committee and Nomination & Remuneration Committee, Effective January 5, 2026
02/01	Pharmaids Pharmaceuticals Limited Appoints Dr. Yogananda Moolemath as Independent Director, Effective January 1, 2026
28/11	Pharmaids Pharmaceuticals appoints P N Vijay as chairman effective December 5, 2025
28/11	Pharmaids Pharmaceuticals Limited Announces Board and Committee Changes
11/11	Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025
18/09/25	Sourabh Hadimani completed the acquisition of 66.50% stake in Anugraha Chemicals P. Ltd. from Pharmaids Pharmaceuticals Limited.
18/08/25	Shankarappa Nagaraja Vinaya Babu completed the acquisition of 7.68% stake in Pharmaids Pharmaceuticals Limited for approximately INR 170 million.
07/08/25	Pharmaids Pharmaceuticals Limited Announces Executive Changes, Effective August 7, 2025
07/08/25	Pharmaids Pharmaceuticals Limited Announces Resignation of S Prasad as the Chief Executive Officer Effective August 07, 2025
07/08/25	Pharmaids Pharmaceuticals CEO S Prasad resigns
07/08/25	Pharmaids Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2025
04/07/25	Sourabh Hadimani signed a letter of intent to acquire 66.50% stake in Anugraha Chemicals P. Ltd. from Pharmaids Pharmaceuticals Limited for approximately INR 110 million.
23/05/25	Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2025
12/02/25	Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024
27/12/24	Shankarappa Nagaraja Vinaya Babu proposed to acquire an additional 26% stake in Pharmaids Pharmaceuticals Limited for approximately INR 570 million.
27/12/24	Shankarappa Nagaraja Vinaya Babu proposed to acquire 26% stake in Pharmaids Pharmaceuticals Limited for approximately INR 570 million.
10/12/24	Pharmaids Pharmaceuticals Arms Gets National Good Laboratory Practice Certification; Shares Drop 5%
13/11/24	Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024
11/11/24	Pharmaids Pharmaceuticals Secures INR125 Million Loan Deal From Chairman
31/10/24	Pharmaids Pharmaceuticals to Extedn INR50 Million Loan to Step-Down Arm
23/10/24	Pharmaids Pharmaceuticals Extends INR60 Million Loan to Subsidiary
09/10/24	Anugraha Chemicals announced that it expects to receive INR 74.354 million in funding from Pharmaids Pharmaceuticals Limited
13/09/24	Pharmaids Pharmaceuticals Secures INR50 Million Loan